
Biote Corp (BTMD) Stock Forecast & Price Target
Biote Corp (BTMD) Analyst Ratings
Bulls say
Biote is at risk of losing market share to competitors if they are unable to effectively defend or protect their patents, trademarks, trade secrets, and other intellectual property. Additionally, closures and disruptions caused by pandemics could impact the company's operations and revenue. However, as a financial analyst, I believe Biote's growth and success in providing personalized hormone optimization solutions to medical practitioners and their patients makes it a strong investment opportunity despite these potential risks.
Bears say
Biote is facing multiple challenges including declining revenue, potential regulatory fines, data security breaches, and competition. The company has had lower than expected revenue and AEBITDA, leading to decreased gross margin and challenges with acquisitions and managing attrition. The company also faces potential risks related to rising interest rates, inflation, and political uncertainty.
This aggregate rating is based on analysts' research of Biote Corp and is not a guaranteed prediction by Public.com or investment advice.
Biote Corp (BTMD) Analyst Forecast & Price Prediction
Start investing in Biote Corp (BTMD)
Order type
Buy in
Order amount
Est. shares
0 shares